Randomized Trial of Maternal Progesterone Therapy
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 102 participants.
Also called NCT02133573
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 102 participants
- Registry
-
NCT02133573
-
- Other papers using this trial's data
- Progesterone for Neurodevelopment in Fetuses With Congenital Heart Defects: A Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02133573. Randomized; quadruple masking; primary purpose treatment. Start 2014-07 (registry gives no type); primary completion 2021-11 (actual). Results posted on 2023-02-28.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Randomized Trial of Maternal Progesterone Therapy
- Condition
- Congenital Heart Disease
- Condition
- Periventricular Leucomalacia
- Condition
- Brain Development
- Condition
- Cardiac Surgery
- Condition
- Neurodevelopmental Disability
- Condition
- Fetal Neuroprotection
- Intervention (Drug)
- Progesterone
- Intervention (Drug)
- Vaginal lubricant
- Lead sponsor
- Children's Hospital of Philadelphia
Record details
- Record id
cardio:ct-nct02133573- Content hash
52245d0371a8c71a395447d6d9cd74a0a447d17c48f710d55c8d04edcce147f6